When Big Pharma Comes Knocking

Public M&A in the Boardroom. 

Are you actively engaged in collaboration discussions? Are you expecting clinical data in the near term? If so, then you might hear a knock at your door from big pharma. Please join us for this interactive, virtual session during which the team of Goodwin M&A lawyers that recently led the sale transactions of MyoKardia and Spark Therapeutics will take you through a public company sale process. While it takes most Boards of Directors several months to navigate through a public company sale, we will help you sign up a transaction in only 60 minutes. 

Interested in attending? Please email Olivia Salvucci to request an invitation.